カテゴリー： GlobalInfoResearch, 世界

アルツハイマー病治療薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Alzheimer's Disease Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9102940）・商品コード：GIR9102940
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月24日（※2024年版があります。お問い合わせください）
・ページ数：122
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、アルツハイマー病治療薬の世界市場について調べ、まとめました。種類別セグメントは、コリンエステラーゼ阻害剤、NMDAアンタゴニスト等、用途別セグメントは、ドラッグストア、小売店、その他等に区分しました。アルツハイマー病治療薬の世界市場概観、メーカー動向、メーカー別アルツハイマー病治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・アルツハイマー病治療薬の市場概観
・アルツハイマー病治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・アルツハイマー病治療薬の企業別販売動向、市場シェア、市場集中度、競争動向
・アルツハイマー病治療薬の世界市場規模
・アルツハイマー病治療薬の北米市場分析（アメリカ、カナダ、メキシコ等）
・アルツハイマー病治療薬のアメリカ市場規模推移
・アルツハイマー病治療薬のカナダ市場規模推移
・アルツハイマー病治療薬のメキシコ市場規模推移
・アルツハイマー病治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・アルツハイマー病治療薬のドイツ市場規模推移
・アルツハイマー病治療薬のイギリス市場規模推移
・アルツハイマー病治療薬のロシア市場規模推移
・アルツハイマー病治療薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・アルツハイマー病治療薬の日本市場規模推移
・アルツハイマー病治療薬の中国市場規模推移
・アルツハイマー病治療薬の韓国市場規模推移
・アルツハイマー病治療薬のインド市場規模推移
・アルツハイマー病治療薬の東南アジア市場規模推移
・アルツハイマー病治療薬の南米市場分析（ブラジル、アルゼンチン等）
・アルツハイマー病治療薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・アルツハイマー病治療薬の種類別分析/販売量、売上、市場シェア（コリンエステラーゼ阻害剤、NMDAアンタゴニスト）
・アルツハイマー病治療薬の用途別分析/市場規模（ドラッグストア、小売店、その他）
・アルツハイマー病治療薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・アルツハイマー病治療薬の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Alzheimer’s is a chronic neurodegenerative disease that usually starts slowly and worsens over time.

Scope of the Report:
The worldwide market for Alzheimer’s Disease Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Alzheimer’s Disease Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Eisai
Forest Laboratories
H. Lundbeck
Johnson and Johnson
Merz Pharma
Novartis
Pfizer

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Cholinesterase Inhibitors
NMDA Antagonists

Market Segment by Applications, can be divided into
Drug Stores
Retail Stores
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Alzheimer’s Disease Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Alzheimer’s Disease Drugs, with price, sales, revenue and global market share of Alzheimer’s Disease Drugs in 2017 and 2018.
Chapter 3, the Alzheimer’s Disease Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alzheimer’s Disease Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Alzheimer’s Disease Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Alzheimer’s Disease Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Alzheimer’s Disease Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Cholinesterase Inhibitors
1.2.2 NMDA Antagonists
1.3 Market Analysis by Applications
1.3.1 Drug Stores
1.3.2 Retail Stores
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eisai
2.1.1 Business Overview
2.1.2 Alzheimer’s Disease Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eisai Alzheimer’s Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Forest Laboratories
2.2.1 Business Overview
2.2.2 Alzheimer’s Disease Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Forest Laboratories Alzheimer’s Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 H. Lundbeck
2.3.1 Business Overview
2.3.2 Alzheimer’s Disease Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 H. Lundbeck Alzheimer’s Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Johnson and Johnson
2.4.1 Business Overview
2.4.2 Alzheimer’s Disease Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson and Johnson Alzheimer’s Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Merz Pharma
2.5.1 Business Overview
2.5.2 Alzheimer’s Disease Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merz Pharma Alzheimer’s Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Alzheimer’s Disease Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Alzheimer’s Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Alzheimer’s Disease Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Alzheimer’s Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Alzheimer’s Disease Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Alzheimer’s Disease Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Alzheimer’s Disease Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Alzheimer’s Disease Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Alzheimer’s Disease Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Alzheimer’s Disease Drugs Market Analysis by Regions
4.1 Global Alzheimer’s Disease Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Alzheimer’s Disease Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Alzheimer’s Disease Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
4.5 South America Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
5 North America Alzheimer’s Disease Drugs by Country
5.1 North America Alzheimer’s Disease Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Alzheimer’s Disease Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Alzheimer’s Disease Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
6 Europe Alzheimer’s Disease Drugs by Country
6.1 Europe Alzheimer’s Disease Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Alzheimer’s Disease Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe Alzheimer’s Disease Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
6.3 UK Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
6.4 France Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Alzheimer’s Disease Drugs by Country
7.1 Asia-Pacific Alzheimer’s Disease Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Alzheimer’s Disease Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Alzheimer’s Disease Drugs Revenue and Market Share by Country (2014-2019)
7.2 China Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
7.5 India Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
8 South America Alzheimer’s Disease Drugs by Country
8.1 South America Alzheimer’s Disease Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Alzheimer’s Disease Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Alzheimer’s Disease Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Alzheimer’s Disease Drugs by Countries
9.1 Middle East and Africa Alzheimer’s Disease Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Alzheimer’s Disease Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Alzheimer’s Disease Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Alzheimer’s Disease Drugs Sales and Growth Rate (2014-2019)
10 Global Alzheimer’s Disease Drugs Market Segment by Type
10.1 Global Alzheimer’s Disease Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Alzheimer’s Disease Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Alzheimer’s Disease Drugs Revenue and Market Share by Type (2014-2019)
10.2 Cholinesterase Inhibitors Sales Growth and Price
10.2.1 Global Cholinesterase Inhibitors Sales Growth (2014-2019)
10.2.2 Global Cholinesterase Inhibitors Price (2014-2019)
10.3 NMDA Antagonists Sales Growth and Price
10.3.1 Global NMDA Antagonists Sales Growth (2014-2019)
10.3.2 Global NMDA Antagonists Price (2014-2019)
11 Global Alzheimer’s Disease Drugs Market Segment by Application
11.1 Global Alzheimer’s Disease Drugs Sales Market Share by Application (2014-2019)
11.2 Drug Stores Sales Growth (2014-2019)
11.3 Retail Stores Sales Growth (2014-2019)
11.4 Others Sales Growth (2014-2019)
12 Alzheimer’s Disease Drugs Market Forecast (2019-2024)
12.1 Global Alzheimer’s Disease Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Alzheimer’s Disease Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Alzheimer’s Disease Drugs Market Forecast (2019-2024)
12.2.2 Europe Alzheimer’s Disease Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Alzheimer’s Disease Drugs Market Forecast (2019-2024)
12.2.4 South America Alzheimer’s Disease Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Alzheimer’s Disease Drugs Market Forecast (2019-2024)
12.3 Alzheimer’s Disease Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Alzheimer’s Disease Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Alzheimer’s Disease Drugs Market Share Forecast by Type (2019-2024)
12.4 Alzheimer’s Disease Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Alzheimer’s Disease Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Alzheimer’s Disease Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Alzheimer's Disease Drugs Picture
Table Product Specifications of Alzheimer's Disease Drugs
Figure Global Sales Market Share of Alzheimer's Disease Drugs by Types in 2018
Table Alzheimer's Disease Drugs Types for Major Manufacturers
Figure Cholinesterase Inhibitors Picture
Figure NMDA Antagonists Picture
Figure Alzheimer's Disease Drugs Sales Market Share by Applications in 2018
Figure Drug Stores Picture
Figure Retail Stores Picture
Figure Others Picture
Figure United States Alzheimer's Disease Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Alzheimer's Disease Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Alzheimer's Disease Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Alzheimer's Disease Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure France Alzheimer's Disease Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure UK Alzheimer's Disease Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Alzheimer's Disease Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Alzheimer's Disease Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure China Alzheimer's Disease Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Alzheimer's Disease Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Alzheimer's Disease Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure India Alzheimer's Disease Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Alzheimer's Disease Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Alzheimer's Disease Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Alzheimer's Disease Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Alzheimer's Disease Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Alzheimer's Disease Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Alzheimer's Disease Drugs Revenue (Value) and Growth Rate (2014-2024)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Alzheimer's Disease Drugs Type and Applications
Table Eisai Alzheimer's Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Forest Laboratories Basic Information, Manufacturing Base and Competitors
Table Forest Laboratories Alzheimer's Disease Drugs Type and Applications
Table Forest Laboratories Alzheimer's Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table H. Lundbeck Basic Information, Manufacturing Base and Competitors
Table H. Lundbeck Alzheimer's Disease Drugs Type and Applications
Table H. Lundbeck Alzheimer's Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson and Johnson Alzheimer's Disease Drugs Type and Applications
Table Johnson and Johnson Alzheimer's Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merz Pharma Basic Information, Manufacturing Base and Competitors
Table Merz Pharma Alzheimer's Disease Drugs Type and Applications
Table Merz Pharma Alzheimer's Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Alzheimer's Disease Drugs Type and Applications
Table Novartis Alzheimer's Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Alzheimer's Disease Drugs Type and Applications
Table Pfizer Alzheimer's Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Alzheimer's Disease Drugs Sales by Manufacturer (2017-2018)
Figure Global Alzheimer's Disease Drugs Sales Market Share by Manufacturer in 2017
Figure Global Alzheimer's Disease Drugs Sales Market Share by Manufacturer in 2018
Table Global Alzheimer's Disease Drugs Revenue by Manufacturer (2017-2018)
Figure Global Alzheimer's Disease Drugs Revenue Market Share by Manufacturer in 2017
Figure Global Alzheimer's Disease Drugs Revenue Market Share by Manufacturer in 2018
Figure Top 3 Alzheimer's Disease Drugs Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Alzheimer's Disease Drugs Manufacturer (Revenue) Market Share in 2018
Figure Global Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure Global Alzheimer's Disease Drugs Revenue and Growth Rate (2014-2019)
Table Global Alzheimer's Disease Drugs Sales by Regions (2014-2019)
Table Global Alzheimer's Disease Drugs Sales Market Share by Regions (2014-2019)
Table Global Alzheimer's Disease Drugs Revenue by Regions (2014-2019)
Figure Global Alzheimer's Disease Drugs Revenue Market Share by Regions in 2014
Figure Global Alzheimer's Disease Drugs Revenue Market Share by Regions in 2018
Figure North America Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure Europe Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure South America Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure North America Alzheimer's Disease Drugs Revenue and Growth Rate (2014-2019)
Table North America Alzheimer's Disease Drugs Sales by Countries (2014-2019)
Table North America Alzheimer's Disease Drugs Sales Market Share by Countries (2014-2019)
Figure North America Alzheimer's Disease Drugs Sales Market Share by Countries in 2014
Figure North America Alzheimer's Disease Drugs Sales Market Share by Countries in 2018
Table North America Alzheimer's Disease Drugs Revenue by Countries (2014-2019)
Table North America Alzheimer's Disease Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Alzheimer's Disease Drugs Revenue Market Share by Countries in 2014
Figure North America Alzheimer's Disease Drugs Revenue Market Share by Countries in 2018
Figure United States Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure Canada Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure Mexico Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure Europe Alzheimer's Disease Drugs Revenue and Growth Rate (2014-2019)
Table Europe Alzheimer's Disease Drugs Sales by Countries (2014-2019)
Table Europe Alzheimer's Disease Drugs Sales Market Share by Countries (2014-2019)
Table Europe Alzheimer's Disease Drugs Revenue by Countries (2014-2019)
Figure Europe Alzheimer's Disease Drugs Revenue Market Share by Countries in 2017
Figure Europe Alzheimer's Disease Drugs Revenue Market Share by Countries in 2018
Figure Germany Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure UK Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure France Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure Russia Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure Italy Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Alzheimer's Disease Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Alzheimer's Disease Drugs Sales by Countries (2014-2019)
Table Asia-Pacific Alzheimer's Disease Drugs Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Alzheimer's Disease Drugs Sales Market Share by Countries 2018
Table Asia-Pacific Alzheimer's Disease Drugs Revenue by Countries (2014-2019)
Figure Asia-Pacific Alzheimer's Disease Drugs Revenue Market Share by Countries 2018
Figure China Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure Japan Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure Korea Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure India Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure Southeast Asia Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure South America Alzheimer's Disease Drugs Revenue and Growth Rate (2014-2019)
Table South America Alzheimer's Disease Drugs Sales by Countries (2014-2019)
Table South America Alzheimer's Disease Drugs Sales Market Share by Countries (2014-2019)
Figure South America Alzheimer's Disease Drugs Sales Market Share by Countries in 2018
Table South America Alzheimer's Disease Drugs Revenue by Countries (2014-2019)
Table South America Alzheimer's Disease Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Alzheimer's Disease Drugs Revenue Market Share by Countries in 2018
Figure Brazil Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure Argentina Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure Colombia Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Alzheimer's Disease Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Alzheimer's Disease Drugs Sales by Countries (2014-2019)
Table Middle East and Africa Alzheimer's Disease Drugs Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Alzheimer's Disease Drugs Sales Market Share by Countries in 2018
Table Middle East and Africa Alzheimer's Disease Drugs Revenue by Countries (2014-2019)
Table Middle East and Africa Alzheimer's Disease Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Alzheimer's Disease Drugs Revenue Market Share by Countries in 2014
Figure Middle East and Africa Alzheimer's Disease Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure UAE Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure Egypt Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure Nigeria Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Figure South Africa Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
Table Global Alzheimer's Disease Drugs Sales by Type (2014-2019)
Table Global Alzheimer's Disease Drugs Sales Share by Type (2014-2019)
Table Global Alzheimer's Disease Drugs Revenue by Type (2014-2019)
Table Global Alzheimer's Disease Drugs Revenue Share by Type (2014-2019)
Figure Global Cholinesterase Inhibitors Sales Growth (2014-2019)
Figure Global Cholinesterase Inhibitors Price (2014-2019)
Figure Global NMDA Antagonists Sales Growth (2014-2019)
Figure Global NMDA Antagonists Price (2014-2019)
Table Global Alzheimer's Disease Drugs Sales by Application (2014-2019)
Table Global Alzheimer's Disease Drugs Sales Share by Application (2014-2019)
Figure Global Retail Stores Sales Growth (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Alzheimer's Disease Drugs Sales, Revenue and Growth Rate (2019-2024)
Table Global Alzheimer's Disease Drugs Sales Forecast by Regions (2019-2024)
Table Global Alzheimer's Disease Drugs Market Share Forecast by Regions (2019-2024)
Figure North America Sales Alzheimer's Disease Drugs Market Forecast (2019-2024)
Figure Europe Sales Alzheimer's Disease Drugs Market Forecast (2019-2024)
Figure Asia-Pacific Sales Alzheimer's Disease Drugs Market Forecast (2019-2024)
Figure South America Sales Alzheimer's Disease Drugs Market Forecast (2019-2024)
Figure Middle East and Africa Sales Alzheimer's Disease Drugs Market Forecast (2019-2024)
Table Global Alzheimer's Disease Drugs Sales Forecast by Type (2019-2024)
Table Global Alzheimer's Disease Drugs Market Share Forecast by Type (2019-2024)
Table Global Alzheimer's Disease Drugs Sales Forecast by Application (2019-2024)
Table Global Alzheimer's Disease Drugs Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List


【掲載企業】

Eisai、Forest Laboratories、H. Lundbeck、Johnson and Johnson、Merz Pharma、Novartis、Pfizer、

★調査レポート[アルツハイマー病治療薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9102940)販売に関する免責事項を必ずご確認ください。
★調査レポート[アルツハイマー病治療薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • オーエスキー病ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100289 / GlobalInfoResearch / 2019年10月10日 / 本調査レポートは、オーエスキー病ワクチンの世界市場について調べ、まとめました。種類別セグメントは、凍結乾燥錠、注射剤等、用途別セグメントは、雌ブタ、子ブタ、イノシシ等に区分しました。オーエスキー病ワクチンの世界市場概観、メーカー動向、メーカー別オーエスキー病ワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・オーエスキー病ワクチンの市場概観 ・オーエスキー病ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・オーエスキー病ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・オーエスキー病ワクチンの世界市場規模 ・オーエスキー病ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・オーエスキー病ワクチンのアメリカ市場規模推移 ・オーエスキー病ワクチンのカナダ市場規模推移 ・オーエスキー病ワクチンのメキシコ市場規模推移 ・オーエスキー病ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The worldwide market for Aujeszky Disease Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Aujeszky Disease Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Zendal group(CZ Vaccines) Kyoritsuseiyaku Corporation Ceva IDEXX MSD Animal...
  • 処方整形外科薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101547 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、処方整形外科薬の世界市場について調べ、まとめました。種類別セグメントは、経口、局所等、用途別セグメントは、病院薬局、オンライン薬局、小売薬局等に区分しました。処方整形外科薬の世界市場概観、メーカー動向、メーカー別処方整形外科薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・処方整形外科薬の市場概観 ・処方整形外科薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・処方整形外科薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・処方整形外科薬の世界市場規模 ・処方整形外科薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・処方整形外科薬のアメリカ市場規模推移 ・処方整形外科薬のカナダ市場規模推移 ・処方整形外科薬のメキシコ市場規模推移 ・処方整形外科薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...The prescription drugs are widely used for orthopedic surgery, which are used to treat arthritis, gout and others. Scope of the Report: The worldwide market for Prescription Orthopedic Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Prescription Orthopedic Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type...
  • 眼感染症薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101222 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、眼感染症薬の世界市場について調べ、まとめました。種類別セグメントは、レボフロキサシン、シプロフロキサシン、その他等、用途別セグメントは、結膜炎、麦粒腫、まぶたの感染、その他等に区分しました。眼感染症薬の世界市場概観、メーカー動向、メーカー別眼感染症薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・眼感染症薬の市場概観 ・眼感染症薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・眼感染症薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・眼感染症薬の世界市場規模 ・眼感染症薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・眼感染症薬のアメリカ市場規模推移 ・眼感染症薬のカナダ市場規模推移 ・眼感染症薬のメキシコ市場規模推移 ・眼感染症薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The worldwide market for Eye Infection Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Eye Infection Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Novartis Allergan Valeant Pharmaceuticals Santen Pharmaceutical Lupin Pharmaceuticals...

    • ◆H&Iグローバルリサーチのお客様（例）◆